Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01286350 · ClinicalTrials.gov registry record · NA
FL3X Study: An Adaptive Intervention to Improve Outcomes for Youth With Type 1 Diabetes (FL3X)
A NA study, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 258
- Enrollment target
NCT01286350: Completed NA study, sponsored by University of North Carolina, Chapel Hill.
NCT01286350 is a NA study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 258 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01286350, a NA study, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 258 participants
- Enrollment target
Study Summary
The purpose of this study is to see if a behavioral intervention for adolescents with type 1 diabetes will improve adherence to T1D self-management activities and improve diabetes outcomes. We expect the intervention to improve diabetes outcomes when compared to usual care.
Primary Outcome
HbA1c will be measured to determine impact on glucose control
Interventions
- BEHAVIORAL FL3X: Flexible Lifestyle Empowering Change
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 258 participants |
| Start Date | 2014-05 |
| Est. Completion | 2018-01 |
| Phase | NA |
What the finished NCT01286350 record still lists
NCT01286350 is an interventional study that assigns participants to a tested intervention. The registered 258 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower).
The record links to 0 conditions, and to 1 intervention - of which FL3X: Flexible Lifestyle Empowering Change is the first listed.
NCT01286350 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01286350 about?
NCT01286350 is a clinical study titled "FL3X Study: An Adaptive Intervention to Improve Outcomes for Youth With Type 1 Diabetes (FL3X)". The purpose of this study is to see if a behavioral intervention for adolescents with type 1 diabetes will improve adherence to T1D self-management activities and improve diabetes outcomes. We expect the intervention to improve diabetes outcomes when compared to usual care.
What is the current status of trial NCT01286350?
This trial is currently completed. It is a NA study. The enrollment target is 258 participants. The study started on 2014-05. Estimated completion is 2018-01.
What interventions are being tested in trial NCT01286350?
The interventions under investigation include: FL3X: Flexible Lifestyle Empowering Change (BEHAVIORAL).
Who is sponsoring clinical trial NCT01286350?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01286350's enrollment target sits among peer trials
258 402nd of 2000 higher than 1,598 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03785288 · 258 participants · Phase 3
Vaginal Cuff Brachytherapy Fractionation Study
- NCT04643002 · 258 participants · Phase 1
Isatuximab in Combination With Novel Agents in RRMM - Master Protocol
- NCT04924322 · 258 participants · Phase 2
Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies
- NCT05043012 · 258 participants · NA
Diagnostic Performance Of Non-Endorectal Coil Multiparametric Magnetic Resonance Imaging Of Prostate With Flexible AIR Coil (DoNEMAC Study)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia